Introduction
Transgastric or transduodenal endoscopic ultrasound (EUS)-guided drainage and, if
needed, necrosectomy has become the modality of choice in the treatment of pancreatic
walled-off necrosis (WON) [1]
[2]
[3]
[4]
[5]
[6]. However, some WON may not be in proximity to the upper gastrointestinal tract or
may extend into the paracolic gutters, the root of the mesentery, or the pelvis, necessitating
multi-gate drainage. In such cases, a percutaneous approach including percutaneous
catheter drainage or surgical techniques including video-assisted retroperitoneal
debridement (VARD) may be required; however, this is associated with considerable
risk of pancreatico-cutaneous fistulas [7]. While EUS-guided transrectal (TR) and transcolonic (TC) drainage of abdominopelvic
abscesses has been described elsewhere [8], only one case report has described the use of this technique in managing WON [9].
Procedure
In this paper, we report our experience with EUS-guided TR or TC drainage and necrosectomy
in nine consecutive patients with culture-proven infected WON who were admitted to
our tertiary referral center. During the study period of January 1, 2020, to December
31, 2022, 91 adult patients (> 18 years) underwent EUS-guided drainage for WON. Permission
for this study was granted by the Center for Regional Development, Capital Region
of Denmark (ID no. R-20075169). No permission from the Regional Ethics Committee was
needed since the study was retrospective.
EUS-guided TR or TC drainage was performed using a curved linear array echoendoscope
(GF-UCT180, Olympus, Japan) and ultrasound scanner (Arietta 850, Hitachi Medical Corporation,
Tokyo, Japan) by: 1) needle puncture of the collection with a 19G needle (ECHO-HD-19-A,
Cook Medical, Bloomington, Indiana, United States); 2) insertion of a 0.025- to 0.035-inch/450-cm
guidewire (VisiGlide 2, Olympus Medical Systems Europe, Hamburg, Germany or Dreamwire,
Boston Scientific Natick, Massachusetts, United States) through the needle; 3) balloon
dilatation of the tract over the wire with a 4- to 8-mm balloon (Hurricane, Boston
Scientific Natick, Massachusetts, United States); and 4) insertion of one or two 7F
double pigtail stents (DPT) of various lengths (Zimmon, Cook Medical, Bloomington,
Indiana, United States). Alternatively, a lumen-apposing metal stent (LAMS) (Hot AXIOS
20 × 10 mm, Boston Scientific, Natick, Massachusetts, United States) with a 7F/4-cm
coaxial double pigtail stent was used ([Fig. 1]). Endoscopic necrosectomy was performed through the working channel of either a
gastroscope or colonoscope (Olympus Medical Systems Europe, Hamburg, Germany) using
forceps, snare or EndoRotator (Interscope Medical, Inc. Worcester, Massachusetts,
United States) at the discretion of the endoscopist. During endoscopic debridement,
irrigation was performed with 0.3% hydrogen peroxide solution. Bowel cleansing was
achieved by administration of a polyethylene glycol (PEG)-based bowel preparation
including Plenvu or macrogel (Movicol) before the endoscopic procedures. Between endoscopic
procedures, antibiotic and/or antifungal treatment was administered depending on microbiological
findings at index drainage procedure and further treatment was adjusted according
to subsequent culture findings. The procedures were performed under conscious sedation
with midazolam and sufentanil, or under general anesthesia, depending on the clinical
condition of the patient. The pigtail stents were removed after 1 year, while the
LAMS was removed after clinical resolution and before discharge from the hospital.
As for transgastric drainage, indwelling coaxial double pigtail stents were left in
place after removal of the LAMS for a year, aiming at minimizing recurrence of pancreatic
fluid collections especially in case of disconnected pancreatic duct syndrome.
Fig. 1 Transcolonic endoscopic ultrasound-guided drainage and necrosectomy for WON with proximity
to the oral transverse colon. a Coronal CT slice depicting a WON (red asterisk) with
proximity to the oral part of the transverse colon (green asterisk) before placement
of lumen-apposing metal stent (LAMS). b Endosonographic view of the WON. c Fluoroscopic
view of the LAMS and double pigtail plastic stent. d Endoscopic view of the LAMS and
coaxial double pigtail plastic stent.
In all patients the treatment strategy including need for step-up was discussed after
thorough review of relevant clinical information and radiological images at a weekly
multidisciplinary pancreas team meeting including advanced endoscopists, surgeons,
gastroenterologists, microbiologists, and radiologists [6].
Results
Overall, nine patients with WON, all with culture-proven infection, according to the
Revised Atlanta classification [10] were included in the study ([Table 1]). In all but two of the patients, the TR/TC drainage was performed in addition to
transgastric drainage and necrosectomy ([Table 1]). Drainage was performed through the colon in seven patients and through the rectum
in two patients. Double pigtail stents were used in six patients and LAMS was used
in three patients.TR/TC necrosectomy was needed in seven patients (78%) ([Video 1]). Drainage was successfully performed in all patients and clinical resolution was
achieved in eight of the nine patients at follow-up (89%). In one patient, a small,
isolated remnant of the WON reoccurred as a psoas abscess and was first drained percutaneously
at the referring hospital and subsequently in our center through the colon. The overall
adverse event rate was 11% (n =1). A transverse colonic perforation occurred in a
patient after faulty insertion of double pigtail stents into what was believed to
be a WON. This was treated with laparotomy and suture repair, followed by an uneventful
recovery (Patient ID 1, [Table 1]). A successful transcolonic drainage was later performed in this case.
Table 1 Overview of patients with WON who underwent transrectal/transcolonic EUS-guided drainage
and necrosectomy.
ID
|
Age, sex
|
Etiology
|
Comorbidity
|
WON size and location
|
Puncture site
|
Index intervention, days since index intervention
|
Indication for transcolonic/transrectal intervention
|
Transcolonic/transrectal necrosectomy
|
Stent, typeand size
|
Adverse events
|
Clinical success
|
Number of transcolonic procedures before resolution
|
M, male; F, female; ASA, American Society of Anesthesiology; WON, walled-off pancreatic
necrosis; ERCP, endoscopic retrograde pancreatography; DPT, double pigtail; VARD,
video-assisted retroperitoneal debridement; PBC, primary biliary cholangitis; LAMS,
lumen-apposing metal stent.
1 A transverse colon perforation occurred during insertion of double pigtail stents,
necessitating surgery (explorative laparotomy with suture repair); however, a further
transcolonic drainage procedure was performed successfully.
|
1
|
27, M
|
Gallstones
|
Diabetes
|
10 × 12 cm, splenic flexure, medial to the descending colon
|
Descending colon
|
Transgastric drainage followed by necrosectomy, 15 days
|
Remnant necrotic collection at the splenic flexure not accessible by transgastric
drainage
|
No
|
7F 12 cm DPT stent
|
Yes, colonic perforation1
|
Yes
|
2
|
2
|
28, M
|
Alcohol
|
None
|
15 × 4 cm, pelvic cavity
|
Rectum
|
Transgastric drainage followed by necrosectomy and VARD, 104 days
|
Slow clinical progression and poor infection control why a multi-gate technique was
used (concomitant transgastric necrosectomy and transrectal drainage)
|
No
|
7F 15 cm DPT stent
|
None
|
Yes
|
3
|
3
|
63, M
|
Alcohol
|
None
|
7 × 3 cm, splenic flexure, medial to the descending colon
|
Descending colon
|
Transgastric drainage followed by necrosectomy, 13 days
|
Remnant necrotic collection at the splenic flexure not accessible by transgastric
drainage
|
Yes
|
7F 6 cm DPT stent
|
None
|
Yes
|
1
|
4
|
50, F
|
Post-ERCP
|
Primary biliary cholangitis and liver transplantation
|
26 × 4 cm, pelvic cavity
|
Rectum
|
Transrectal, N/R
|
Transrectal drainage and necrosectomy used as single-therapy due to WON location
|
Yes
|
7F 15 cm DPT stent
|
None
|
Yes
|
4
|
5
|
40, F
|
Ischemic pancreatitis following newly liver transplantation
|
Neuroendocrine tumor with previous Whipple procedure
|
24 × 16 cm, at the left paracolic gutter extending medially to the mesenteric root
|
Transverse colon
|
Concomitant transgastric and transcolonic drainage and necrosectomy at index procedure
|
Refractory septic shock in an immuno-compromised patient
|
Yes
|
LAMS (Hot AXIOS stent, 20 mm x 10 mm)
|
None
|
Yes
|
2
|
6
|
33, F
|
Post-ERCP
|
None
|
9 × 7 cm, at the mesenteric root, infero-medial to the transverse colon
|
Transverse colon
|
Transcolonic
|
Collection not accessible by transgastric approach
|
Yes
|
LAMS (Hot AXIOS stent, 20 mm x 10 mm)
|
None
|
Yes
|
3
|
7
|
73, F
|
Gallstones
|
Hypertension
|
11 × 6 cm, at the splenic flexure, extending medially to the descending colon
|
Descending colon
|
Transgastric drainage and necrosectomy, 39 days
|
Remnant necrotic collection at the splenic flexure not accessible by transgastric
drainage
|
Yes
|
7F 6 cm DPT stent
|
None
|
Yes
|
2
|
8
|
46, M
|
Gallstones
|
None
|
24 × 7 cm, at the left paracolic gutter extending medially to the mesenteric root
|
Descending colon
|
Transgastric drainage and necrosectomy, 62 days
|
Remnant collection at left paracolic gutter not accessible by transgastric approach
|
Yes
|
LAMS (Hot AXIOS stent, 20 mm x 10 mm)
|
None
|
Yes
|
1
|
9
|
35, M
|
Alcohol
|
None
|
8 × 4 cm, at the splenic flexure extending medially to the descending colon
|
Descending colon
|
Transgastric, 32 days
|
Remnant collection at the splenic flexure not accessible by transgastric drainage
|
Yes
|
7F 8 cm DPT stent
|
None
|
Yes
|
2
|
Endoscopic transcolonic necrosectomy.Video 1
Discussion
No patient in our cohort developed pancreatico-cutaneous fistula, a complication associated
with substantial morbidity and more commonly encountered in patients drained through
percutaneous routes or surgical approaches including VARD and open necrosectomy [4]
[7]. We believe that endoluminal drainage and necrosectomy minimize that risk. Moreover,
necrotic collections extending into the root of the mesentery may be challenging to
drain sufficiently with percutaneous techniques including VARD due to a central location
in the abdomen. We find that transcolonic drainage in collections inaccessible to
a transgastric or transduodenal route may serve as a minimally invasive alternative
to percutaneous or surgical techniques.
EUS-guided TR/TC drainage may be performed both with DPT and LAMS. However, when puncturing
from the transverse colon, which is intraperitoneally located, the use of LAMS is
preferred to seal the trajectory.
Conclusions
While our study is limited by its small number of patients, it is the first to demonstrate
the technical feasibility of EUS-guided TR/TC drainage and necrosectomy in patients
with WON. TR/TC drainage of WON appears to be safe and practical, and the combination
of transgastric and transcolonic drainage may be recommended for multi-gate treatment
of WON extending to the paracolic gutters, the root of the mesentery, or in the presacral
space. Hypothetically, bacterial translocation from the colon and subsequent superinfection
of the WON may be an issue. However, the WON in our cohort were already infected,
as confirmed by culturing findings. Finally, it remains to be explored in a prospective
setting whether EUS-guided TR/TC drainage improves clinical outcomes.